Surgery Partners, Inc.

SGRY Healthcare Medical Care Facilities

Surgery Partners, Inc.’s revenue for fiscal 2025 (year ended December 2025) was $3.3 billion, up 6.24% from fiscal 2024.

Revenue
+2.75%
EPS
−500.0%
Free cash flow
−60.6%
Total debt
+4.92%

Quarter to June 2026, against a year earlier

23.18 0.02 +0.09%
Market cap
$3.0B
P/E
0.0×
Fwd P/E
−35.3×
Dividend yield
—
F-score
4/9
Altman Z
0.75
Beneish M
−2.52
Dividend safety
4/100

Surgery Partners, Inc. (SGRY) Price to free cash flow

Alert me on Price to free cash flow

As of 5 November 2026, Surgery Partners, Inc. (SGRY) trades at a price to free cash flow of 15.6×. Over the past ten years it has ranged from 2.3× (July 2020) to 144× (December 2021); the current reading is higher than 66% of that period. That is in line with the Medical Care Facilities industry median of 16.0× and below the Healthcare sector median of 21.1×.

Price to free cash flow, daily

Embed this chart

Annual newest first

Period Price to free cash flow Change
FY2025 8.1× (35.45%)
FY2024 12.6× (26.94%)
FY2023 17.2× (35.15%)
FY2022 26.5× (75.64%)
FY2021 109× 1,921.50%
FY2020 5.4× (47.60%)
FY2019 10.3× 171.28%
FY2018 3.8× (46.33%)
FY2017 7.1× (18.24%)
FY2016 8.6× (40.31%)

Quarterly newest first

Period Price to free cash flow Change
Jun 2026 11.3× 84.43%
Mar 2026 6.1× (24.51%)
Dec 2025 8.1× (29.78%)
Sep 2025 11.6× (10.18%)
42 more quarters

Against its own ten years

Low 2.3× High 144×
Ten-year median 11.0×
Current reading's percentile 66

Price to free cash flow against peers

What Price to free cash flow is

Price to Free Cash Flow Ratio shows how much investors pay for each dollar of cash a company generates after its capital spending.

Stock Price ÷ ((Operating Cash Flow (TTM) + Property, Plant, Equipment Change (Net) (TTM) + Intangible Assets Change (Net) (TTM)) ÷ (Shares (Basic, Weighted) (latest quarter)))

The full definition of Price to free cash flow →

More on SGRY